“By 2025, global sales of temperature-controlled drugs and biologics are expected to reach $416 billion. These figures are part of a larger global biopharma market expected to exceed $1.43 trillion,” says the official website of MiPharma, a global platform that connects “like-minded supply chain professionals who share a common passion for pharma.”
Militzer & Münch Germany has been a member of MiPharma since 2023 in order to further expand this growing business area. Holger Seehusen, Managing Director of M&M Germany, and Charlotte Dürr, Group Project Manager for Pharma, took part in the three-day global MiPharma conference in Abu Dhabi in May.
“MiPharma supports us in closing our network gaps and offers us industry contacts and specialist knowledge, even in difficult markets,” says Charlotte Dürr. “For example, through a network partner, we can now also help a German customer who has shipments for hospitals in a war zone in the Middle East. In addition, I have initiated a number of connections between other M&M locations and MiPharma members. To name just one: There is a large pharmaceutical customer that our colleagues at M&M India would like to win and who requires freight forwarding services in Hong Kong and warehousing in the UK.”
MiPharma members also have access to newly developed benefits such as: B. very affordable solutions for purchasing disposable thermal packaging or renting live data loggers, as well as training platforms and risk assessment tools.
Image source: miPharma